Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire12/05 21:00

RZLT Stock Rises on FDA's Orphan Designation for Rare Disease Drug

Zacks 12/04 22:05

Sector Update: Health Care Stocks Higher Tuesday Afternoon

MT Newswires12/04 02:36

Yun Zhong, PhD, Joins Wedbush Securities as Senior Vice President, Equity Research, Biotechnology

Businesswire12/03 21:30

FDA Grants Orphan Drug Designation to Rezolute's Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism

GlobeNewswire12/03 21:00

Is Rezolute, Inc. (RZLT) the Best Multibagger Stock to Buy Heading Into 2025?

Yahoo Finance11/16 14:29